ES8802518A1 - Un procedimiento para preparar derivados de isoxazol y furano. - Google Patents

Un procedimiento para preparar derivados de isoxazol y furano.

Info

Publication number
ES8802518A1
ES8802518A1 ES556812A ES556812A ES8802518A1 ES 8802518 A1 ES8802518 A1 ES 8802518A1 ES 556812 A ES556812 A ES 556812A ES 556812 A ES556812 A ES 556812A ES 8802518 A1 ES8802518 A1 ES 8802518A1
Authority
ES
Spain
Prior art keywords
preparation
phenoxyalkyl
isoxazoles
furans
antiviral agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556812A
Other languages
English (en)
Other versions
ES556812A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of ES8802518A1 publication Critical patent/ES8802518A1/es
Publication of ES556812A0 publication Critical patent/ES556812A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

LOS DERIVADOS DE ISOXAZOL Y FURANO (I), DONDE NO EXCLUSIVAMENTE, Y ES UN PUENTE ALQUILENO C3-9 INTERRUMPIDO OPCIONALMENTE POR UNA INSATURACION, Z ES NITROGENO O R5C, R5 ALCANOILO INFERIOR, R ALQUILO INFERIOR, M 0 O 1, R1 Y R2 SON HALOGENO, NITRO O TRIFLUOROMETILO, R3 Y R4 ALQUILO INFERIOR C1-3; SE OBTIENE HACIENDO REACCIONAR UN COMPUESTO (II), DONDE HA1 ES CLORO, BROMO O YODO CON UNA SAL DE METAL ALCALINA, DE OTRO (III), EN PRESENCIA DE UNA BASE COMO CARBONATO, HIDROXIDO, METOXIDO, SODICOS O POTASICOS Y DE UN DISOLVENTE INERTE COMO EL DIOXANO O EL BENCENO. SON AGENTES ANTIVIRALES. *FORMULA* L
ES556812A 1985-07-02 1986-06-25 Un procedimiento para preparar derivados de isoxazol y furano. Expired ES8802518A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75134885A 1985-07-02 1985-07-02

Publications (2)

Publication Number Publication Date
ES8802518A1 true ES8802518A1 (es) 1988-07-01
ES556812A0 ES556812A0 (es) 1988-07-01

Family

ID=25021592

Family Applications (5)

Application Number Title Priority Date Filing Date
ES556812A Expired ES8802518A1 (es) 1985-07-02 1986-06-25 Un procedimiento para preparar derivados de isoxazol y furano.
ES556811A Expired ES8802517A1 (es) 1985-07-02 1986-06-25 Un procedimiento para preparar fenoxialquil (substituido con heterocido)-isoxazoles y furanos.
ES557778A Expired ES8802153A1 (es) 1985-07-02 1987-12-04 Procedimiento para preparar derivados de isoxazol y furano.
ES557779A Expired ES8801649A1 (es) 1985-07-02 1987-12-07 Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isoxazoles y furanos
ES557780A Expired ES8801651A1 (es) 1985-07-02 1987-12-07 Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isozazoles y furanos

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES556811A Expired ES8802517A1 (es) 1985-07-02 1986-06-25 Un procedimiento para preparar fenoxialquil (substituido con heterocido)-isoxazoles y furanos.
ES557778A Expired ES8802153A1 (es) 1985-07-02 1987-12-04 Procedimiento para preparar derivados de isoxazol y furano.
ES557779A Expired ES8801649A1 (es) 1985-07-02 1987-12-07 Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isoxazoles y furanos
ES557780A Expired ES8801651A1 (es) 1985-07-02 1987-12-07 Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isozazoles y furanos

Country Status (21)

Country Link
EP (2) EP0207454B1 (es)
JP (2) JPH0768242B2 (es)
KR (2) KR900001315B1 (es)
AR (4) AR241705A1 (es)
AT (2) ATE107645T1 (es)
AU (2) AU589190B2 (es)
CA (2) CA1280753C (es)
DE (3) DE3689924D1 (es)
DK (2) DK171275B1 (es)
ES (5) ES8802518A1 (es)
FI (2) FI85021C (es)
GR (2) GR861697B (es)
IE (2) IE59755B1 (es)
IL (2) IL79308A (es)
MX (4) MX2954A (es)
MY (1) MY102908A (es)
NO (2) NO164977C (es)
NZ (1) NZ216678A (es)
PH (2) PH23197A (es)
PT (2) PT82892B (es)
ZA (2) ZA864872B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1280753C (en) * 1985-07-02 1991-02-26 Philip Michael Carabateas Process for preparing heterocyclic substituted- phenoxyalkyl isoxazoles and-furans
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
US5051437A (en) * 1986-06-24 1991-09-24 Sterling Drug Inc. Thiazolylphenoxyalkylisoxazoles, related compounds, and their use as antiviral agents
GB8807275D0 (en) * 1988-03-26 1988-04-27 Synphar Lab Inc Chemical compounds
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
EP0362531B1 (en) 1988-09-01 1999-11-10 Bayer Corporation A human rhinovirus receptor protein that inhibits virus infectivity
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines
US5070090A (en) * 1989-05-15 1991-12-03 Janssen Pharmaceutica N.V. Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
US4942241A (en) * 1989-08-21 1990-07-17 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
US5175178A (en) * 1989-08-21 1992-12-29 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5110821A (en) * 1989-08-18 1992-05-05 Sterling Drug Inc. 1,3,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US4945164A (en) * 1989-08-18 1990-07-31 Sterling Drug Inc. 1,3,4-Oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents and intermediates thereof
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
EP0468257B1 (en) * 1990-07-20 1999-09-01 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
IT1247509B (it) * 1991-04-19 1994-12-17 Univ Cagliari Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
US5175177A (en) * 1991-07-17 1992-12-29 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5349068A (en) * 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5514781A (en) * 1994-04-11 1996-05-07 Bayer Corporation Use of azoles as virucidal agents in solutions of biologically active proteins
US5514679A (en) * 1994-05-13 1996-05-07 Sterling Winthrop Inc. Therapeutic phenoxyalklpyridazines and intermediates therefor
US5453433A (en) * 1994-05-13 1995-09-26 Sterling Winthrop Inc. Thiadiazoles and antipicornaviral compositions
WO2005005423A1 (en) 2003-07-02 2005-01-20 F. Hoffmann-La Roche Ag Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators
US7790720B2 (en) * 2005-03-31 2010-09-07 Ucb Pharma, S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
US8993604B2 (en) 2009-06-30 2015-03-31 Siga Technologies, Inc. Treatment and prevention of dengue virus infections
AP2012006094A0 (en) * 2009-06-30 2012-02-29 Siga Technologies Inc Treatment and prevention of dengue virus infections.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451476A (en) * 1982-12-13 1984-05-29 Sterling Drug Inc. Isoxazoles as antiviral agents
NZ209209A (en) * 1983-08-29 1988-02-12 Sterling Drug Inc Substituted phenyl-aliphatic isoxazole derivatives and pharmaceutical compositions
CA1280753C (en) * 1985-07-02 1991-02-26 Philip Michael Carabateas Process for preparing heterocyclic substituted- phenoxyalkyl isoxazoles and-furans

Also Published As

Publication number Publication date
AU587622B2 (en) 1989-08-24
EP0207453A2 (en) 1987-01-07
DE3686677T2 (de) 1993-03-11
CA1280753C (en) 1991-02-26
NO862651D0 (no) 1986-07-01
ES557778A0 (es) 1988-04-01
KR870001202A (ko) 1987-03-12
IL79309A (en) 1990-11-29
EP0207454A2 (en) 1987-01-07
DK171275B1 (da) 1996-08-19
ZA864873B (en) 1987-02-25
ES8801649A1 (es) 1988-02-16
ES556811A0 (es) 1988-07-01
EP0207454B1 (en) 1992-09-09
NO862650L (no) 1987-01-05
FI862794A0 (fi) 1986-07-01
EP0207453B1 (en) 1994-06-22
KR900001314B1 (ko) 1990-03-08
ES8802153A1 (es) 1988-04-01
EP0207454A3 (en) 1988-08-10
NO165023C (no) 1990-12-12
KR900001315B1 (ko) 1990-03-08
GR861697B (en) 1986-11-04
AR244686A1 (es) 1993-11-30
IL79308A0 (en) 1986-10-31
DE3689924T4 (de) 1995-05-11
KR870001205A (ko) 1987-03-12
DE3689924T2 (de) 1995-01-19
ES557780A0 (es) 1988-02-16
NO165023B (no) 1990-09-03
FI862795A0 (fi) 1986-07-01
ES8801651A1 (es) 1988-02-16
FI862795A (fi) 1987-01-03
DK173467B1 (da) 2000-12-04
ES8802517A1 (es) 1988-07-01
CA1299176C (en) 1992-04-21
IL79308A (en) 1991-01-31
NO164977B (no) 1990-08-27
JPH0768242B2 (ja) 1995-07-26
IL79309A0 (en) 1986-10-31
MX2954A (es) 1993-11-01
ZA864872B (en) 1987-02-25
PT82892B (pt) 1994-09-30
ATE107645T1 (de) 1994-07-15
AR242572A1 (es) 1993-04-30
DK312986D0 (da) 1986-07-01
AU5945686A (en) 1987-01-08
FI85021C (fi) 1992-02-25
IE59755B1 (en) 1994-03-23
EP0207453A3 (en) 1988-11-23
PT82891A (en) 1986-08-01
DK313086D0 (da) 1986-07-01
DE3689924D1 (de) 1994-07-28
JPS6216480A (ja) 1987-01-24
JPH0819128B2 (ja) 1996-02-28
PH23197A (en) 1989-05-29
IE861723L (en) 1987-01-02
AR241705A1 (es) 1992-11-30
IE66234B1 (en) 1995-12-13
ES556812A0 (es) 1988-07-01
ES557779A0 (es) 1988-02-16
NZ216678A (en) 1989-10-27
DE3686677D1 (de) 1992-10-15
MX9100029A (es) 1993-01-01
AU589190B2 (en) 1989-10-05
AR242573A1 (es) 1993-04-30
FI85021B (fi) 1991-11-15
IE861724L (en) 1987-01-02
PT82891B (pt) 1988-05-27
PT82892A (pt) 1987-01-26
NO862650D0 (no) 1986-07-01
FI862794A (fi) 1987-01-03
DK313086A (da) 1987-01-03
MX9100033A (es) 1993-01-01
NO862651L (no) 1987-01-05
NO164977C (no) 1990-12-05
AU5945786A (en) 1987-01-08
PH22321A (en) 1988-07-29
MX9100032A (es) 1993-01-01
GR861695B (en) 1986-11-04
ATE80397T1 (de) 1992-09-15
DK312986A (da) 1987-01-03
MY102908A (en) 1993-03-31
JPS6216479A (ja) 1987-01-24

Similar Documents

Publication Publication Date Title
ES8801651A1 (es) Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isozazoles y furanos
JO1351B1 (en) Chemical compounds
EP1035123A4 (en) NEW HETEROCYCLIC COMPOUNDS
ES8802148A1 (es) Procedimiento para preparar derivados de acido quinoloncarboxilico
AU551811B2 (en) Imidazodiazepines
EP0259835A3 (en) Pyridazinone derivatives
IE893211L (en) Benzoxazepinone Process
IE781467L (en) 4"-ureido-oleandomycin derivatives
ES8704947A1 (es) Un procedimiento para preparar un derivado de imidazopirida-zina
GB8610369D0 (en) Heterocyclic compounds
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
ES8606325A1 (es) Procedimiento para preparar compuestos de 3-amino-2,3-dihi- dro-1-benzoxepina
ES8402303A1 (es) Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo (3.2.0) hepteno.

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: STERLING WINTHROP INC.

PC1A Transfer granted
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20040512